ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618093; 2) Community: the network communities that were significantly associated with the response to NSC 618093; 3) Molecule: the relationships between components within communities and NSC 618093; 4) MDR: the compounds that were significantly associated with the NSC 618093.

NSC Compound Enrichment Correlation
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0474314077111079 0.10941657
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.0474314077111079 -0.2186492
NSC 651590 ANTINEOPLASTIC-651590 0.0474314077111079 -0.042963043
NSC 668269 Null 0.0474314077111079 -0.075543544
NSC 677249 Null 0.0474314077111079 0.24874444
NSC 682866 Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- 0.0474314077111079 0.17038496
NSC 691250 Null 0.0474314077111079 0.25392316
NSC 724603 S-(dimethylarsino)-3-mercapto-1,2-propyl di-2-chloro-2-phenylacetate 0.0474314077111079 0.016440726
NSC 81052 Streptonigrin analog (MeO-N3) 0.0474314077111079 -0.053619288
NSC 2604 D.b.t.c. 0.0474314077111082 -0.21843717
Total:119  Current:112    [First] [Prev] [Next] [Last]